Showing results (1-10 of 1,132) with videos related to
Sort By:
Pageof 114
Statistics in Medicine|May 4, 2004
The independent statistician for data monitoring committeesDavid L DeMets, Thomas R FlemingJournal of Clinical Epidemiology|July 14, 2020
Achieving effective informed oversight by DMCs in COVID clinical trialsDavid L DeMets, Thomas R FlemingStatistics in Medicine|September 27, 2002
Monitoring clinical trials: issues and controversies regarding confidentialityThomas R Fleming, Susan Ellenberg, David L DeMetsClinical Trials (London, England)|April 10, 2018
Data Monitoring Committees: Current issuesThomas R Fleming, Susan S Ellenberg, David L DeMetsScience and Engineering Ethics|November 25, 2016
Institutional Responsibility and the Flawed Genomic Biomarkers at Duke University: A Missed Opportunity for Transparency and AccountabilityDavid L DeMets, Thomas R Fleming, Gail Geller, et al.Journal of Biopharmaceutical Statistics|June 14, 2014
Enhancing trial integrity by protecting the independence of data monitoring committees in clinical trialsThomas R Fleming, Charles H Hennekens, Marc A Pfeffer, et al.NEJM Evidence|August 27, 2024
The Case for Access to Data Monitoring Committee ChartersDeborah Zarin, Janet T Wittes, Thomas R Fleming, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2008
Clinical trial design and selected drug safety issues for antibiotics used to treat community-acquired pneumoniaBruce M PsatyStatistics in Medicine|June 28, 2012
Current development in clinical trials: issues old and newDavid L DeMetsPageof 114